BRIEF published on 11/21/2024 at 10:05, 1 year 9 months ago Nabaltec AG Reports Stable Earnings in Q3 2024 Revenue Growth Market Position Nabaltec AG Functional Fillers Q3 2024 Earnings
PRESS RELEASE published on 11/21/2024 at 10:00, 1 year 9 months ago Nabaltec AG continues solid earnings performance in third quarter of 2024 Nabaltec AG reports solid earnings performance with a 1.5% increase in consolidated revenues and 28.2% rise in EBIT for the third quarter of 2024 Revenues EBIT 2024 Nabaltec AG Earnings Performance
BRIEF published on 10/10/2024 at 09:06, 1 year 11 months ago Nabaltec Maintains Strong Growth Outlook Following Conference Insights Nabaltec ATH Demand White Powder Investment Boehmite Sales Share Valuation
PRESS RELEASE published on 10/10/2024 at 09:01, 1 year 11 months ago Original-Research: Nabaltec (von NuWays AG): Buy Analysis of Nabaltec by NuWays AG reveals strong demand for core product ATH, growing capacities for gap filler, emphasizing attractive growth potential with Q3 performance expected to be positive. Shares remain undervalued NuWays AG Growth Potential Undervalued Shares Nabaltec ATH
BRIEF published on 08/23/2024 at 09:11, 2 years ago Nabaltec AG Reports Strong Q2, Raises FY24 Guidance Cash Flow NuWays AG FY24 Guidance Nabaltec AG Q2 Earnings
PRESS RELEASE published on 08/23/2024 at 09:06, 2 years ago Original-Research: Nabaltec AG (von NuWays AG): BUY Nabaltec AG research by NuWays AG reveals strong Q2 figures, with sales up 11% yoy and EBIT jumping 79% yoy. FY24 guidance raised with sales growth and improved margins expected NuWays AG Research FY24 Guidance Nabaltec AG Q2 Figures
BRIEF published on 08/22/2024 at 10:09, 2 years ago Nabaltec AG Publishes Interim Report January to June 2024: Revenues on Track in Second Quarter Revenue Growth EBIT Margin Interim Report Nabaltec AG Functional Fillers
PRESS RELEASE published on 08/22/2024 at 10:04, 2 years ago Nabaltec AG publishes interim report January to June 2024: Revenues on track in second quarter Nabaltec AG's interim report Jan-Jun 2024 shows revenue growth of 2.2% to EUR 108.4M. EBIT reaches EUR 10.9M. Forecast for 2024: 2%-4% revenue growth and EBIT margin 8%-10% Revenue Growth EBIT Forecast Interim Report Nabaltec AG
BRIEF published on 06/27/2024 at 09:06, 2 years 2 months ago Nabaltec AG: Positive Outlook and Conservative Guidance Operational Improvements Valuation BUY Rating Nabaltec AG Boehmite
PRESS RELEASE published on 06/27/2024 at 09:01, 2 years 2 months ago Original-Research: Nabaltec AG (von NuWays AG): Kaufen NuWays AG releases research update on Nabaltec AG. Despite recent share price increase, Nabaltec shows operational improvements, promising boehmite optionality, and attractive valuation Operational Improvements Valuation NuWays AG Nabaltec AG Boehmite Optionality
Published on 09/12/2026 at 02:35, 1 day 21 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 2 days 1 hour ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days 2 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 7 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 day 6 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 16 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 2 days 1 hour ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 days 1 hour ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 2 days 4 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 17 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 3 days 4 hours ago Availability of the 2026 Interim Financial Report
